Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.
bit.bio has raised $30.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.
bit.bio's investors include Resilience, Tencent, BlueYard Capital, ARCH Venture Partners, Foresite Capital.
bit.bio is headquartered in Cambridge, United Kingdom.
Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.
bit.bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"bit.bio — Funding & Investors." VCBacked, December 16, 2024, https://www.vcbacked.co/company/bitbio-cambridge-2. Accessed October 21, 2026.
VCBacked. (2024). bit.bio — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/bitbio-cambridge-2
{{cite web |title=bit.bio — Funding & Investors |url=https://www.vcbacked.co/company/bitbio-cambridge-2 |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated